Press release
Investigation announced for Investors in shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
An investigation on behalf of investors in Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares over potential wrongdoing.
Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Vanda Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.
On February 25, 2019 a lawsuit was filed against Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
over alleged violations of Federal Securities Laws. The plaintiff claims that between November 4, 2015 and February 11, 2019, thedefendants made false and/or misleading statements and/or failed to disclose that Vanda was engaged in a fraudulent scheme in which it promoted the off-label use of Fanapt and Hetlioz, that Vanda was fraudulently receiving drug reimbursements from the government by abusing Medicare, Medicaid, and Tricare programs, that as a result of the scheme, Vanda faced legal action from the government, that Vanda’s promotional materials for Fanapt and Hetlioz were false and misleading, garnering regulatory scrutiny from the U.S. Food and Drug Administration, and that as a result, defendants’ statements about Vanda’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) here
News-ID: 1811798 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Vanda
Vanda Writer Releases New LGBT Historical Novel - Do You Know Dorothy?
Vanda Writer Releases New LGBT Historical Novel - Do You Know Dorothy?
Vanda Writer is pleased to announce the release of her new LGBT Historical novel, Do You Know Dorothy? This is book fifth book in the Juliana Series.
Can a group of elderly drag queens save a 1950s nightclub from being taken over by the mob?
It's 1956 and television is stealing Alice's nightclub audience. Known as Al to everyone…
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor Market Over …
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor -Pipeline Insight, 2020
The global Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor Market research report 2020 provides a basic overview of the industry including definitions, classifications, applications, and industry chain structure. The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor market report provides information regarding market size, share, trends, growth, cost structure, global market competition landscape, market drivers, challenges and opportunity, capacity, revenue, and forecast.
The…
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Alert: Investigation over pot …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vanda Pharmaceuticals Inc. (NASDAQ: VNDA.
Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those Vanda Pharmaceuticals Inc. (NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Vanda Pharmaceuticals Inc. (NASDAQ: VNDA…
Insomnia Therapeutics Drugs Market 2020 Research and Clinical Analysis - Vanda P …
The Insomnia Therapeutics Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Buy The Report:
https://www.marketinsightsreports.com/report/purchase/05211249906?mode=su?source=openpr&Mode=RJ
The report…
Global Sleep Disorder Therapies Market 2019 - Sleep Number, Vanda Pharmaceutical …
Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.
In 2018, the global Sleep Disorder Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
Apex Market Research, recently published a detailed market research study focused on the “Sleep Disorder Therapies…
Global Insomnia Market : Leading Players –Pfizer, Merck, Eisai, Meda Consumer …
Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.
Global Insomnia Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends…
